Chauhan AS, Thakur M, Meena KL, Yadav K. Efficacy of sofosbuvir and daclatasvir in compensated chronic hepatitis C infection: A single center, open-label and proof of concept study. Int. J. of Health Sci. [Internet]. 2022 Aug. 11 [cited 2026 Jun. 1];6(S5):7984-96. Available from: https://sciencescholar.us/journal/index.php/ijhs/article/view/10510